EMCITATE 350 micrograms, dispersible tablet 60 tablets
Active ingredients: Tiratricol
Commercialized according to BDPMDispensing in France: Prescription only
Dispersible tablet60 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- EMCITATE 350 microgrammes, comprimé dispersible
- Pharmaceutical form
- comprimé dispersible
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC aluminium de 60 comprimé(s)
- Marketing authorisation holder
- RARE THYROID THERAPEUTICS INTERNATIONAL AB (SUEDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 15 May 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68773605CIP73031070CIP133400930310700Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TIRATRICOLcomprimé | 350 microgrammes · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.